Disruption of Androgen Metabolism, Regulation and Effects: Involvement of Steroidogenic Enzymes
January 2014
in “
edoc (University of Basel)
”
Studysummary This research suggests that fluoxymesterone, an anabolic steroid, may inhibit a key enzyme, potentially contributing to cardiovascular issues by affecting cortisol's activation of mineralocorticoid receptors.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on edoc.unibas.ch →